Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus.
Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus.
复制标题
DOI:
10.1089/hum.2008.205
复制
发表时间:
2009-04
影响因子:
4.2
通讯作者:
Kang-Jian Zhang;Yi Gang Wang;Xin Cao;S. Zhong;R. Wei;Y. Wu;Xue-tian Yue;Gong-chu Li;Xin Yuan Liu
中科院分区:
文献类型:
--
作者:
Kang-Jian Zhang;Yi Gang Wang;Xin Cao;S. Zhong;R. Wei;Y. Wu;Xue-tian Yue;Gong-chu Li;Xin Yuan Liu
Interleukin (IL)-24 is an excellent therapeutic gene for cancer therapy. In this work, IL-24 was inserted into Ad.sp-E1A(Delta24), an oncolytic adenovirus with a 24-bp deletion in the E1A gene, which was driven by the survivin promoter to form Ad.sp-E1A(Delta24)-IL-24. Ad.sp-E1A(Delta24)-IL-24 has an excellent antitumor effect in vitro for human nasopharyngeal, liver, lung, and cervical carcinoma cell lines but does no or little damage to normal cell lines L-02 and WI38. Furthermore, it achieved nearly complete inhibition (although not elimination) of NCI-H460 lung carcinoma growth in nude mice. The antitumor efficacy of Ad.sp-E1A(Delta24)-IL-24 on NCI-H460 cells was clearly mediated by apoptosis, because it induced caspase-3 and poly(ADP-ribose) polymerase cleavage. This is the first report of Ad.sp-E1A(Delta24)-IL-24 with such an excellent, broad, and specific antitumor effect in vitro and nearly complete inhibition of lung tumor growth in vivo.